Results 11 to 20 of about 17,529 (206)

Teicoplanin-Induced Anaphylactic Reaction in Children: A Case Report

open access: yesPharmacy, 2018
Teicoplanin is now increasingly used as a first-line prophylactic therapy for major surgical procedures, treatment of methicillin-resistant Staphylococcus aureus infections and for those with reported penicillin allergy.
Godwin Oligbu, Leila Ahmed
doaj   +2 more sources

Immobilised teicoplanin does not demonstrate antimicrobial activity against Staphylococcus aureus [PDF]

open access: yesScientific Reports, 2022
Antibacterial bone biomaterial coatings appeal to orthopaedics, dentistry and veterinary medicine. Achieving the successful, stable conjugation of suitable compounds to biomaterial surfaces is a major challenge.
S. Britton   +5 more
doaj   +2 more sources

Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia

open access: yesInfection and Drug Resistance, 2018
Ching-Yen Tsai,1 Chen-Hsiang Lee,1,2 Chun-Chih Chien,3 I-Ling Chen4 1Division of Infectious Diseases, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; 2Chang Gung University College of Medicine, Kaohsiung, Taiwan ...
Tsai CY, Lee CH, Chien CC, Chen IL
doaj   +1 more source

Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type

open access: yesDrug Design, Development and Therapy, 2023
Yifan Wang,1,2,* Fen Yao,2,* Shenglong Chen,3 Xin Ouyang,4 Jinhua Lan,5 Zheng Wu,2 Yirong Wang,2 Jingchun Chen,2 Xipei Wang,6,7 Chunbo Chen1 1Department of Critical Care Medicine, Shenzhen People’s Hospital, The Second Clinical Medical College of
Wang Y   +9 more
doaj   +1 more source

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections

open access: yesClinical Pharmacology: Advances and Applications, 2016
Kazuaki Matsumoto,1 Erika Watanabe,1 Naoko Kanazawa,1 Tomohide Fukamizu,1 Akari Shigemi,1 Yuta Yokoyama,1,2 Kazuro Ikawa,2 Norifumi Morikawa,2 Yasuo Takeda1 1Department of Clinical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences,
Matsumoto K   +8 more
doaj   +1 more source

The Effectiveness of Linezolid and Teicoplanin for Managing Infections After Burn Injuries: A Retrospective Study. [PDF]

open access: yesHealth Sci Rep
ABSTRACT Background and Aims Gram‐positive infections in burn patients present significant treatment challenges. This study compared the efficacy and safety of linezolid vs. teicoplanin for managing such infections in a clinical setting. Methods We conducted a retrospective study involving 77 burn patients with confirmed Gram‐positive infections at ...
Zendehdel A   +4 more
europepmc   +2 more sources

<i>Burkholderia vietnamiensis</i> Bacteraemia After Lung Transplantation in a Patient With Diffuse Panbronchiolitis. [PDF]

open access: yesRespirol Case Rep
Persistent Burkholderia cepacia complex bacteraemia occurred after lung transplantation for diffuse panbronchiolitis. Despite apparent in vitro susceptibility to meropenem, bacteraemia persisted and antimicrobial therapy was modified. This case highlights the importance of integrating clinical evolution with antimicrobial susceptibility testing when ...
Ryo T, Iwata KI, Chen-Yoshikawa TF.
europepmc   +2 more sources

Teicoplanin

open access: yesMedical Clinics of North America, 1995
Teicoplanin, a new glycopeptide antibiotic similar to vancomycin, has proved effective in the treatment of various gram-positive infections in both the normal and the immunocompromised host. In vitro activity against most gram-positive organisms is equal to or greater than that of vancomycin.
K W, Shea, B A, Cunha
openaire   +2 more sources

Drug–drug interaction signals between loop diuretics and teicoplanin during acute kidney injury evaluated using Japanese spontaneous adverse drug event reports

open access: yesScientific Reports, 2023
Teicoplanin can cause acute kidney injury, but little is known about the risk of acute kidney injury when teicoplanin is co-administered with loop diuretics (a powerful diuresis), which can alter renal hemodynamics and glomerular filtration rate.
Toshinori Hirai   +5 more
doaj   +1 more source

Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy

open access: yesPharmaceutics, 2022
The dosage regimen of vancomycin, teicoplanin and daptomycin remains controversial for critically ill patients undergoing continuous renal replacement therapy (CRRT).
Jiaojiao Chen   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy